Abstract:Abstract The development of efficient aggregation‐induced emission (AIE) active probes is crucial for disease diagnosis, particularly for tumors and cardiovascular diseases. Current AIE‐active probes primarily focus on improving their water solubility to resist aggregation, thereby achieving an initial fluorescence‐off state. However, the complex biological environment can cause undesirable aggregation, resulting in false signals. To address this issue, we have ingeniously introduced an azo group into the AIE luminogen (AIEgen), developing a reductase‐activated AIE probe, Azo‐quinoline‐malononitrile (QM)‐PN, for imaging hypoxic environments. In this probe, the azo group promotes intramolecular motion through rapid E / Z isomerization, causing the excited state energy to dissipate via non‐radiative decay, thus turning off the initial fluorescence. In the presence of reductase, Azo‐QM‐PN is reduced and cleaved to produce the hydrophobic AIEgen NH 2 ‐QM‐PN, which subsequently aggregates and generates an in situ AIE signal, thereby imaging the hypoxic environment with reductase. Encapsulation of Azo‐QM‐PN with DSPE‐PEG 2000 results in the formation of the nanoprobe Azo‐QM‐PN NPs, which can effectively penetrate cell membranes, specifically illuminate tumor cells, monitor fluctuations in azo reductase levels, and deeply penetrate and image multicellular tumor spheroids, demonstrating potential for hypoxic tumor imaging. Additionally, the nanoprobe Azo‐QM‐PN NPs can selectively image hypoxic atherosclerotic plaque tissues, showing potential for detecting atherosclerosis. Therefore, in this study, we successfully developed an enzyme‐activated AIE probe for imaging hypoxic environments, laying the foundation for further clinical applications.

A Novel Fluorescent Probe Derived from Isophorone and Its Application in Imaging in Vivo Hypoxia

An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging

Novel Strategy for Validating the Existence and Mechanism of the "gut-liver axis" in Vivo by a Hypoxia-Sensitive NIR Fluorescent Probe.

A Novel Off-on Fluorescent Probe for Imaging of Hypoxia in Tumor Cell

A Novel Long-Wavelength Off-on Fluorescence Probe for Nitroreductase Analysis and Hypoxia Imaging.

Hypoxia Imaging in Cells and Tumor Tissues Using a Highly Selective Fluorescent Nitroreductase Probe.

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

A Novel HPQ-based Fluorescent Probe for the Visualization of Carbon Monoxide in Zebrafish

Highly Selective Imaging of Lysosomal Azoreductase under Hypoxia Using Ph-Regulated and Target-Activated Fluorescent Nanoprobes

Development of a Hypoxia-Activated Red-Emission Fluorescent Probe for in Vivo Tumor Microenvironment Imaging and Anti-Tumor Therapy

An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells

Near-Infrared Fluorescent Probes for Hypoxia Detection via Joint Regulated Enzymes: Design, Synthesis, and Application in Living Cells and Mice.

A two-photon mitochondria-targeting azo reductase probe for imaging in tumor cells and mice

Supramolecular fluorescence nanoprobe loaded with azobenzene for the detection of azoreductase: Selective light-up of hypoxic cells

Ultrasensitive near-infrared fluorescence probe activated by nitroreductase for in vivo hypoxia detection

A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

A General Approach to Design Dual Ratiometric Fluorescent and Photoacoustic Probes for Quantitatively Visualizing Tumor Hypoxia Levels in Vivo

Rational Construction of a Reversible Arylazo-Based NIR Probe for Cycling Hypoxia Imaging in Vivo.

Fluorescent Probe for Hypoxia-triggered Imaging and Cancer Therapy

A novel near-infrared fluorescence off-on probe for imaging hypoxia and nitroreductase in cells and in vivo